Protection From H1N1 Flu Is The Same As From Seasonal Flu

Protection From H1N1 Flu Is The Same As From Seasonal Flu.
The new H1N1 flu seems to divide up many characteristics with the seasonal flu it has fundamentally replaced, a unusual study indicates. "Our results are further confirmation that 2009 pandemic H1N1 and seasonal flu have equivalent transport dynamics free articles. People seem to be similarly transmissible when ill with either pandemic or seasonal flu, and the viruses are likely to sprawl in similar ways," said Benjamin Cowling, lead inventor of a study appearing in the June 10 issue of the New England Journal of Medicine.

The solid news is that this means the preventive measures form authorities have been recommending, such as frequent hand washing, should be equally powerful against pandemic flu antiaging. "Influenza is very difficult to contain, but widely known measures including the availability of pandemic H1N1 vaccines should be able to take the edge off the worst of any further epidemics," added Cowling, who is an assistant professor at the School of Public Health at the University of Hong Kong.

Cowling and his colleagues followed 284 household members of 99 individuals who had tested clear-cut for H1N1. Eight percent of the household contacts also mow ruin with the H1N1 virus, about the same forwarding rate as seen for the seasonal flu (9 percent), the researchers found.

Viral shedding (when the virus replicates and leaves the body), as well as the paragon of current sickness, were also like for the two types of flu. The "attack rate" (meaning the adjust of people in the entire population who get sick) for H1N1 was higher than that for seasonal flu and the adjustment was most pronounced centre of children. The authors hypothesized that this might be due to the fact that younger men and women seem to have lower natural immunity to the virus.

The patients in this swatting who were given oseltamivir (Tamiflu) did seem to have reduced antibody levels. "This would suggest that perchance oseltamivir may result in a less vigorous immune response than consumers who are not treated with this drug ," said Dr John J Treanor, professor of pharmaceutical and of microbiology and immunology at the University of Rochester Medical Center.

So "That is very novel from studies looking at seasonal flu, where there doesn't appear to be any essence of oseltamivir on antibody response. This should be looked at more closely. It's potentially high-ranking in terms of long-term susceptibility to re-infection. Susceptibility might be new in someone treated with oseltamivir who is not vaccinated. They might have enhanced susceptibility," Treanor added.

A understudy review in the journal found that giving Tamiflu prophylactically (as a retardation measure) to people confined in close quarters - in this case, martial installations - seemed to slow outbreaks. Flu is also more likely to spread and spread faster in enclosed places such as schools and hospitals, in reckoning to military facilities.

In this study, Tamiflu was given to 1100 personnel out of a all-out of 1175 personnel. Before the intervention, 6,4 percent of individuals were infected, compared with only 0,6 percent after Tamiflu was introduced. On average, a man who came down with H1N1 dissemination the virus to only 0,11 additional individuals after the intervention, versus almost two family before exercise. Although a vaccine is nearby for the 2009 H1N1 pandemic strain, Tamiflu might be an election in areas where the vaccine is not definitively obtainable, stated the authors, who are with the Singapore Ministry of Defence and the National University of Singapore.